Press release
Dravet Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Companies- Takeda, Eisai, Stoke Therapeutics
Dravet Syndrome Clinical Trials
Key Takeaways from the Dravet Syndrome Pipeline Report
Over 15+ Dravet Syndrome pipeline therapies are in various stages of development, and their anticipated acceptance in the Dravet Syndrome market would significantly increase market revenue.
Leading Dravet Syndrome companies developing novel drug candidates to improve the Dravet Syndrome treatment landscape include Takeda, Eisai, Stoke Therapeutics, and others.
Promising Dravet Syndrome pipeline therapies in various stages of development include Soticlestat, Larcaserin,STK-001, and others.
Download sample report @ https://www.delveinsight.com/report-store/dravet-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Dravet Syndrome Overview
Dravet Syndrome is a severe form of epilepsy characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, speech impairment, ataxia, hypotonia, sleep disturbances, and other health problems.
Dravet Syndrome Foundation, states that DS is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures.
Dravet Syndrome Pipeline Analysis: Drug Profile
Lorcaserin: Eisai
Lorcaserin, a serotonin 2C receptor agonist, is being developed by Eisai. Lorcaserin works by selectively activating serotonin 2C receptors in the brain, through the activation GABAergic inhibitory interneuron, expected to suppress seizure of Dravet syndrome by increasing synaptic suppression from GABAergic. Although approval for the obesity indication has been voluntarily withdrawn, due to the request from Dravet syndrome patient groups, the extended access program has been continued in the United States, and the Phase III study is underway for this indication. The US FDA granted ODD for the treatment of Dravet Syndrome. Currently, the drug is in Phase III trials.
Discover more about the emerging Dravet Syndrome drugs @ https://www.delveinsight.com/report-store/dravet-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Dravet Syndrome Key Companies
Takeda
Eisai
Stoke Therapeutics
And others
Dravet Syndrome Pipeline Therapies
Soticlestat
Larcaseri
STK-001
And others
Dravet Syndrome Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Dravet Syndrome Pipeline Report
Coverage: Global
Key Dravet Syndrome Companies: Takeda, Eisai, Stoke Therapeutics, and others
Key Dravet Syndrome Pipeline Therapies: Soticlestat, Larcaserin, STK-001, and others
Find out more about the Dravet Syndrome treatment options in development @ https://www.delveinsight.com/sample-request/dravet-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Leading Reports by DelveInsight:
· Asthma Diagnostic Devices Market
· Chronic Obstructive Pulmonary Disease Treatment Devices Market
· Airway Management Devices Market
· Cough Assist Devices Market
· Pulse Oximeters Market
· Hemodialysis Catheter Devices Market
· Chronic Spontaneous Urticaria Market
· Gender Dysphoria Market
· Germany Healthcare Outlook
· Biopsy Devices Pipeline Insight
· Bacterial Conjunctivitis Market
· Infliximab Biosimilar Insight
· Eosinophilic Asthma Market
· Cushing Syndrome Market
· Functional Dyspepsia Market
· Peripherally Inserted Central Catheters (PICC) Devices Market
Get detailed sample report by visiting here: https://www.delveinsight.com/sample-request/dravet-syndrome-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight:
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dravet Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Companies- Takeda, Eisai, Stoke Therapeutics here
News-ID: 3584229 • Views: …
More Releases from DelveInsight Business Research LLP
Dry Eye Disease Treatment Market Outlook Report 2032 | Alcon Inc., AbbVie Inc., …
DelveInsight's Dry Eye Disease Treatment Market Insights Report 2032 provides the current and forecast market analysis, individual leading Dry Eye Disease Treatment Companies market shares, challenges, Dry Eye Disease Treatment Market Drivers, barriers, trends, and key market Dry Eye Disease Treatment companies in the market.
To read more about the latest highlights related to the Dry Eye Disease Treatment Market, get a snapshot of the key highlights entailed in the Market…
Digital Biopsy Market Size Report 2032 | DermaSensor, Inc., SciBase, VITA IMAGIN …
DelveInsight's Digital Biopsy Market Insights Report 2032 provides the current and forecast market analysis, individual leading Digital Biopsy Companies market shares, challenges, Digital Biopsy Market Drivers, barriers, trends, and key market Digital Biopsy companies in the market.
To read more about the latest highlights related to the Digital Biopsy Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/digital-biopsy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Digital Biopsy Market…
Sinuscope Market Forecast Report 2032 | Olympus Corporation, Boston Scientific C …
DelveInsight's Sinuscope Market Insights Report 2032 provides the current and forecast market analysis, individual leading Sinuscope Companies market shares, challenges, Sinuscope Market Drivers, barriers, trends, and key market Sinuscope companies in the market.
To read more about the latest highlights related to the Sinuscope Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/sinuscope-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Sinuscope Market Report
• The Sinuscope Market is estimated to…
Skull Clamps Market Forecast Report 2032 | Integra LifeSciences Corporation, PRO …
DelveInsight's Skull Clamps Market Insights Report 2032 provides the current and forecast market analysis, individual leading Skull Clamps Companies market shares, challenges, Skull Clamps Market Drivers, barriers, trends, and key market Skull Clamps companies in the market.
To read more about the latest highlights related to the Skull Clamps Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/skull-clamp-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Skull Clamps Market…
More Releases for Dravet
Dravet Syndrome Market Forecast 2025-2034: Comprehensive Analysis And Growth Opp …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Dravet Syndrome Market?
There has been significant growth in the Dravet Syndrome market size in the preceding years. Forecasted to expand from $0.37 billion in 2024 to $0.40 billion in 2025, this robust growth signifies a compound annual growth rate (CAGR) of 9.0%. This monumental…
Dravet Syndrome Market Poised for Growth with New Treatment Advances 2034
The Dravet Syndrome Market Is Set To Grow At An Estimated CAGR Of 7.3% From 2025 To 2034, Rising From $1.3 Billion In 2024 To $2.5 Billion By 2034.
On March 20, 2025, Exactitude Consultancy., Ltd. released a research report titled Dravet Syndrome Market 2025-2034 This report offers a new perspective on the Dravet Syndrome Market covering an extensive range of aspects including market overview, expenditure analysis, import trends, segmentation, key…
Dravet Syndrome Treatment Market Is Booming Worldwide | Biocodex, Zogenix, Pfize …
The "Dravet Syndrome Treatment Market" intelligence report, just published by USD Analytics Market, covers a micro-level study of important market niches, product offers, and sales channels. to determine market size, potential, growth trends, and competitive environment, the Dravet Syndrome Treatment Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the…
Dravet Syndrome Market Size, Share And Growth Analysis For 2023-2032
"According to the research report, the global dravet syndrome market was valued at USD 227.72 million in 2022 and is expected to reach USD 557.17 million by 2032, to grow at a CAGR of 9.4% during the forecast period."
Get Sample with Latest Trends and Future Advancements @ https://www.polarismarketresearch.com/industry-analysis/dravet-syndrome-market/request-for-sample
Polaris Market Research has recently published its latest analysis on Dravet Syndrome Market 2023: By Types, Applications, Size, Share, Key Players & Regions…
Dravet Syndrome Treatment Market Overview
Dravet syndrome, also known as severe myoclonic epilepsy of infancy (SMEI), is a rare and debilitating neurological disorder that primarily affects infants and young children. It is characterized by recurrent, prolonged seizures that are often resistant to conventional antiepileptic medications. Additionally, individuals with Dravet syndrome may experience developmental delays, cognitive impairment, behavioral issues, and other associated health challenges.
The rarity of Dravet syndrome, with an estimated prevalence of approximately 1 in…
Dravet Syndrome Treatment Market to Increase Exponentially During 2028
Coherent Market Insights report on the Dravet Syndrome Treatment Market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period from 2021 to 2028. The report provides the overall market value of the Dravet Syndrome Treatment Market for the period of 2021 to 2028, with 2020 as the base year and 2028 as the forecast…
